Evidence map›Paper›PMID 25349169›Full record

ArticleMolecular psychiatry2015

Genetic background of extreme violent behavior.

J Tiihonen, M-R Rautiainen, H M Ollila, E Repo-Tiihonen, M Virkkunen, A Palotie, O Pietiläinen, K Kristiansson, M Joukamaa, H Lauerma and 6 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 215 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A CommonGenes · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 4 countries.

J Tiihonen1] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden [2] Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland [3] National Institute for Health and Welfare, Helsinki, Finland.
M-R RautiainenNational Institute for Health and Welfare, Helsinki, Finland.
H M Ollila1] National Institute for Health and Welfare, Helsinki, Finland [2] Stanford University Center for Sleep Sciences, Palo Alto, CA, USA.
E Repo-TiihonenDepartment of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
M Virkkunen1] Department of Psychiatry, University of Helsinki, Institute of Clinical Medicine, Helsinki, Finland [2] Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland.
A Palotie1] Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, England [2] Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA [3] Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA [4] Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland [5] Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
O PietiläinenNational Institute for Health and Welfare, Helsinki, Finland.
K KristianssonNational Institute for Health and Welfare, Helsinki, Finland.
M JoukamaaSocial Psychiatry Unit, School of Health Sciences, University of Tampere, Finland.
H Lauerma1] National Institute for Health and Welfare, Helsinki, Finland [2] Psychiatric Hospital for Prisoners, Turku, Finland [3] University of Turku, Turku, Finland.
J SaarelaFinnish Genome Center, Helsinki, Finland.
S TyniThe Criminal Sanctions Agency, Helsinki, Finland.
H VartiainenThe Criminal Sanctions Agency, Helsinki, Finland.
J PaananenUniversity of Eastern Finland, Bioinformatics Center, Kuopio, Finland.
D GoldmanLaboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USA.
T Paunio1] National Institute for Health and Welfare, Helsinki, Finland [2] Department of Psychiatry, University of Helsinki, Institute of Clinical Medicine, Helsinki, Finland [3] Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Eastern Finland · FIHelsinki University Hospital · FIKarolinska Institutet · SENational Institute on Alcohol Abuse and Alcoholism · USTampere University · FIUniversity of Helsinki · FIWellcome Sanger Institute · GB

Funding

Integrative genetics of behavior with high throughput technologiesZIAAA000301 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GOLDMAN, DAVID · 2009 to 2025
$68.6M
Genetic influences on alcohol use disorder in Native AmericansZIAAA000281 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GOLDMAN, DAVID · 2009 to 2025
$6.7M
MOLECULAR GENETIC STUDIES ON ALCOHOLISM IN AMERICAN INDIANS--SOUTHWESTERN TRIBEZ01AA000281 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GOLDMAN, DAVID · 1990 to 2008
$1.1M
Intramural NIH HHS Z01 AA000281
6 · The paper itself

Abstract

In developed countries, the majority of all violent crime is committed by a small group of antisocial recidivistic offenders, but no genes have been shown to contribute to recidivistic violent offending or severe violent behavior, such as homicide. Our results, from two independent cohorts of Finnish prisoners, revealed that a monoamine oxidase A (MAOA) low-activity genotype (contributing to low dopamine turnover rate) as well as the CDH13 gene (coding for neuronal membrane adhesion protein) are associated with extremely violent behavior (at least 10 committed homicides, attempted homicides or batteries). No substantial signal was observed for either MAOA or CDH13 among non-violent offenders, indicating that findings were specific for violent offending, and not largely attributable to substance abuse or antisocial personality disorder. These results indicate both low monoamine metabolism and neuronal membrane dysfunction as plausible factors in the etiology of extreme criminal violent behavior, and imply that at least about 5-10% of all severe violent crime in Finland is attributable to the aforementioned MAOA and CDH13 genotypes.

Indexed as

ViolenceAdultAntisocial Personality DisorderCadherinsCohort StudiesFemaleFinlandGenetic Association StudiesGenotypeHumansMaleMiddle AgedMonoamine OxidasePolymorphism, Single NucleotideCadherinsH-cadherinMonoamine Oxidase

Identifiers

PMID25349169
PMCPMC4776744
OpenAlexW2090718524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.